TLR1/2-stimulated DCs “prime” HSCs via IL-1β
Open Access
- 6 October 2022
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 140 (14) , 1576-1578
Abstract
Bone marrow dendritic cells (BMDCs) are increasingly recognized as an important cellular component of the hematopoietic stem cell (HSC) perivascular niche. In tKeywords
This publication has 10 references indexed in Scilit:
- IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC functionBlood, 2022
- IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in miceBlood, 2022
- Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selectionJournal of Experimental Medicine, 2021
- Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidityExperimental Hematology, 2020
- Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in miceBlood, 2019
- Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive FitnessCell Stem Cell, 2017
- Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanismsBlood Cancer Journal, 2016
- Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewalNature Cell Biology, 2016
- Toll-like receptor alterations in myelodysplastic syndromeLeukemia, 2013
- Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDSBlood, 2012